Back
Aprea Therapeutics Stock Price Chart
10 stocks to buy for the next leg of this rally
Get the full list here FREE
Sell
46
APRE
Aprea Therapeutics
Last Price:
$1.74
Seasonality Move:
-4.95%
7 Day Trial
ALL ACCESS PASS
$
7
10 Best Stocks to Own in 2025
Get your copy now FREE!-
The current trend is relatively stagnant and APRE is experiencing slight selling pressure.
Aprea Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.72 | Buy |
| 20-day SMA: | 1.71 | Buy |
| 50-day SMA: | 1.77 | Buy |
| 200-day SMA: | 2.93 | Sell |
| 8-day EMA: | 1.73 | Buy |
| 20-day EMA: | 1.71 | Buy |
| 50-day EMA: | 1.89 | Sell |
| 200-day EMA: | 2.92 | Sell |
Aprea Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 54.47 | Buy |
| Chaikin Money Flow: | -21772 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.6 - 1.8) | Buy |
| Bollinger Bands (100): | (1.62 - 3.44) | Sell |
Aprea Therapeutics Technical Analysis
| May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aprea Therapeutics Stock
Is Aprea Therapeutics Stock a Buy?
-
Aprea Therapeutics share price is 1.81 while APRE 8-day simple moving average is 1.72, which is a Buy signal.
-
The stock price of APRE is 1.81 while Aprea Therapeutics 20-day SMA is 1.71, which makes it a Buy.
-
Aprea Therapeutics 50-day simple moving average is 1.77 while APRE share price is 1.81, making it a Buy technically.
-
APRE stock price is 1.81 and Aprea Therapeutics 200-day simple moving average is 2.93, creating a Sell signal.
APRE Technical Analysis vs Fundamental Analysis
Sell
46
Aprea Therapeutics (APRE)
is a Sell
Is Aprea Therapeutics a Buy or a Sell?
-
Aprea Therapeutics stock is rated a SellThe current Aprea Therapeutics [APRE] share price is $1.81. The Score for APRE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Aprea Therapeutics Stock Info
Market Cap:
10M
Price in USD:
1.81
Share Volume:
94.1K
Aprea Therapeutics 52-Week Range
52-Week High:
5.01
52-Week Low:
1.41
Sell
46
Aprea Therapeutics (APRE)
is a Sell
Aprea Therapeutics Share Price Forecast
-
What is the Aprea Therapeutics stock price today?The Aprea Therapeutics stock price is 1.81 USD today.
-
Will APRE stock go up or go down?Aprea Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aprea Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aprea Therapeutics is overvalued.
Is Aprea Therapeutics Stock a Buy?
-
Aprea Therapeutics share price is 1.81 while APRE 8-day exponential moving average is 1.73, which is a Buy signal.
-
The stock price of APRE is 1.81 while Aprea Therapeutics 20-day EMA is 1.71, which makes it a Buy.
-
Aprea Therapeutics 50-day exponential moving average is 1.89 while APRE share price is 1.81, making it a Sell technically.
-
APRE stock price is 1.81 and Aprea Therapeutics 200-day simple moving average is 2.92, creating a Sell signal.
Fundamental Analysis of Aprea Therapeutics
Is Aprea Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.56 per share, and an increase next year of $0.06 per share.
Technical Analysis of Aprea Therapeutics
Should I short Aprea Therapeutics stock?
-
APRE Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Aprea Therapeutics is a Sell
-
Aprea Therapeutics Relative Strength Index (RSI) is 54.47, which suggest Aprea Therapeutics is overbought
-
The Bollinger Bands (25) for Aprea Therapeutics is (1.6 - 1.8), which suggest Aprea Therapeutics is a Sell
-
The Bollinger Bands (100) for Aprea Therapeutics is (1.62 - 3.44), which suggest Aprea Therapeutics is a Sell
* Aprea Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.